{"id":23446,"date":"2026-07-03T13:14:41","date_gmt":"2026-07-03T11:14:41","guid":{"rendered":"https:\/\/osloeconomics.no\/?p=23446"},"modified":"2026-07-03T13:14:44","modified_gmt":"2026-07-03T11:14:44","slug":"new-publication-on-the-use-of-expert-elicitation-in-health-economic-analyses","status":"publish","type":"post","link":"https:\/\/osloeconomics.no\/en\/new-publication-on-the-use-of-expert-elicitation-in-health-economic-analyses\/","title":{"rendered":"New publication on the use of expert elicitation in health economic analyses"},"content":{"rendered":"\n<p class=\"wp-block-paragraph\">Together with researchers from the University of Oslo and representatives from the pharmaceutical industry, Christoffer Bugge, Erik Magnus S\u00e6ther and Francisco Oteiza at Oslo Economics have published a peer-reviewed article on the systematic use of expert elicitation in PharmacoEconomics.<\/p>\n\n\n\n<p class=\"wp-block-paragraph\">We have analysed how structured expert elicitation can be combined with early-phase clinical evidence to inform health economic evaluations and reimbursement decisions.<br>Using a Norwegian case study in lung cancer,&nbsp; we show that cost-effectiveness results based on phase II evidence supplemented with expert judgement are consistent with those obtained when phase III trial data become available.<\/p>\n\n\n\n<p class=\"wp-block-paragraph\">The findings suggest that expert elicitation can support earlier (potentially conditional) reimbursement decisions in situations with limited evidence.<\/p>\n\n\n\n<p class=\"wp-block-paragraph\">This work is funded by CONNECT, a public\u2013private partnership.<\/p>\n\n\n\n<p class=\"wp-block-paragraph\">The article is available here: <a href=\"https:\/\/link.springer.com\/article\/10.1007\/s41669-026-00656-9?utm_source=rct_congratemailt&amp;utm_medium=email&amp;utm_campaign=oa_20260618&amp;utm_content=10.1007%2Fs41669-026-00656-9\">https:\/\/link.springer.com\/article\/10.1007\/s41669-026-00656-9?utm_source=rct_congratemailt&amp;utm_medium=email&amp;utm_campaign=oa_20260618&amp;utm_content=10.1007%2Fs41669-026-00656-9<\/a><\/p>\n\n\n\n<p class=\"wp-block-paragraph\"><\/p>\n","protected":false},"excerpt":{"rendered":"<p>Oslo Economics has published a peer-reviewed article on the systematic use of expert elicitation in PharmacoEconomics.<\/p>\n","protected":false},"author":4,"featured_media":23431,"comment_status":"open","ping_status":"open","sticky":false,"template":"","format":"standard","meta":{"_acf_changed":false,"footnotes":""},"categories":[88],"tags":[],"class_list":["post-23446","post","type-post","status-publish","format-standard","has-post-thumbnail","hentry","category-health-and-life-science"],"acf":[],"_links":{"self":[{"href":"https:\/\/osloeconomics.no\/en\/wp-json\/wp\/v2\/posts\/23446","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/osloeconomics.no\/en\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/osloeconomics.no\/en\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/osloeconomics.no\/en\/wp-json\/wp\/v2\/users\/4"}],"replies":[{"embeddable":true,"href":"https:\/\/osloeconomics.no\/en\/wp-json\/wp\/v2\/comments?post=23446"}],"version-history":[{"count":1,"href":"https:\/\/osloeconomics.no\/en\/wp-json\/wp\/v2\/posts\/23446\/revisions"}],"predecessor-version":[{"id":23449,"href":"https:\/\/osloeconomics.no\/en\/wp-json\/wp\/v2\/posts\/23446\/revisions\/23449"}],"wp:featuredmedia":[{"embeddable":true,"href":"https:\/\/osloeconomics.no\/en\/wp-json\/wp\/v2\/media\/23431"}],"wp:attachment":[{"href":"https:\/\/osloeconomics.no\/en\/wp-json\/wp\/v2\/media?parent=23446"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/osloeconomics.no\/en\/wp-json\/wp\/v2\/categories?post=23446"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/osloeconomics.no\/en\/wp-json\/wp\/v2\/tags?post=23446"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}